classic
swine
fever
csf
highli
contagi
viral
diseas
pig
caus
major
econom
loss
worldwid
specif
drug
current
avail
effect
treatment
csfv
infect
rna
interfer
rnai
technolog
depend
effect
deliveri
system
sever
effect
vector
recent
develop
three
retrovir
plasmid
contain
sirna
gene
target
differ
region
n
pro
construct
replicationincompet
retrovir
vector
produc
human
embryo
kidney
cell
line
retrovir
plasmid
transfect
cell
infect
replicationincompet
retrovir
vector
screen
sirna
stabli
express
cell
clone
growth
csfv
sirna
stabli
express
cell
clone
result
reduct
viral
genom
copi
h
postinfect
small
cell
show
infect
indirect
immunofluoresc
microscopi
effect
inhibit
viru
replic
persist
h
retrovir
vectormedi
rnai
therefor
use
studi
specif
function
viral
gene
associ
csfv
replic
may
potenti
therapeut
applic
rna
interfer
rnai
natur
posttranscript
gene
silenc
mechan
induc
nucleotid
nt
small
interf
rna
sirna
molecul
homolog
target
gene
jana
et
al
sinc
discoveri
rnai
regard
virologist
promis
method
suppress
viral
infect
appli
success
inhibit
replic
human
anim
virus
includ
hepat
c
viru
hepat
b
viru
sarscov
vitro
vivo
classic
swine
fever
csf
highli
contagi
diseas
pig
caus
infect
csfv
notifi
diseas
world
organ
anim
health
oie
csf
caus
great
econom
loss
pig
industri
worldwid
particularli
asia
latin
america
eastern
europ
diseas
first
recogn
china
continu
major
epizoot
china
zhu
et
al
csfv
belong
genu
pestiviru
famili
flavivirida
genom
consist
singlestrand
sens
rna
kb
singl
larg
open
read
frame
orf
encod
polyprotein
meyer
et
al
translat
polyprotein
cleav
viral
structur
nonstructur
peptid
nto
cterminu
n
pro
ce
ms
meyer
et
al
elber
et
al
ruggli
et
al
tautz
et
al
n
pro
atyp
cystein
proteas
autoproteolyt
activ
cleav
viral
polyprotein
via
ci
hydrolysi
gener
nterminu
capsid
protein
c
rumenapf
et
al
n
pro
also
essenti
evad
cellular
antivir
defens
system
protect
cell
doublestrand
rnainduc
apoptosi
ruggli
et
al
indispens
cofactor
uncleav
format
infecti
particl
nterminu
provid
serin
proteas
activ
moulin
et
al
previou
studi
vitrotranscrib
sirna
molecul
target
n
pro
repress
effect
csfv
replic
xu
et
al
show
sirna
capabl
specif
effici
inhibit
csfv
replic
rnai
potenti
antivir
strategi
csfv
anim
system
vitro
transcrib
sirna
limit
applic
overcom
sirna
deliveri
system
use
retrovir
schuck
et
al
adenovir
chen
et
al
lentivir
vector
miest
et
al
report
retrovir
deliveri
wellrecogn
effici
mean
introduc
genet
materi
cell
effect
cell
cultur
use
gener
transgen
anim
barquinero
et
al
combin
vectorbas
sirnagener
system
retrovir
deliveri
highli
effici
transfect
stabl
suppress
specif
gene
express
possibl
explor
see
front
matter
elsevi
bv
right
reserv
tabl
list
shrna
sequenc
studi
target
name
sequenc
shrna
b
gacggatccggataggtagggtgacaggttcaagagacctgtcaccctacctatccttttttggaaaagcttgca
tgcaagcttttccaaaaaaggataggtagggtgacaggtctcttgaacctgtcaccctacctatccggatccgtc
gacggatccgaaccctgaagtggattagttcaagagactaatccacttcagggttcttttttggaaaagcttgca
tgcaagcttttccaaaaaagaaccctgaagtggattagtctcttgaactaatccacttcagggttcggatccgtc
ggaggatccgaggcatataccagtagtcattcaagagatgactactggtatatgcctcttttttggaaaagcttcgg
ccgaagcttttccaaaaaagaggcatataccagtagtcatctcttgaatgactactggtatatgcctcggatcctcc
c
ggaggatccggacagtgggatggataggttcaagagacctatccatcccactgtccttttttggaaaagcttcgg
c
ccgaagcttttccaaaaaaggacagtgggatggataggtctcttgaacctatccatcccactgtccggatcctcc
mean
sens
strand
mean
antisens
strand
c
mean
control
shrna
sequenc
b
target
gene
sens
strand
exampl
complementari
oligonucleotid
design
singlestrand
overhang
bamh
singlestrand
overhang
hind
iii
ligat
psilenc
vector
sequenc
enzym
site
underlin
oligonucleotid
encod
hairpin
sequenc
specif
mrna
target
loop
sequenc
separ
two
complementari
domain
ttcaagaga
polythymidin
tract
termin
transcript
tttttt
new
approach
prevent
therapi
classic
swine
fever
retrovir
vectormedi
rna
interfer
studi
inhibitori
effect
csfv
replic
cell
result
show
sirna
stabli
integr
target
cell
inhibit
effici
csfv
replic
vitro
studi
therefor
provid
experiment
basi
develop
promis
anticsfv
method
also
new
approach
studi
viral
infect
replic
pig
kidney
cell
line
passag
virul
csfv
strain
shimen
obtain
institut
veterinari
drug
control
china
posit
anticsfv
serum
neg
control
serum
prepar
describ
previous
sequenc
n
pro
gene
genbank
access
scan
signatur
sequenc
aan
two
design
nt
candid
sequenc
describ
previous
xu
et
al
chosen
sirna
n
pro
rnai
target
within
also
select
studi
sequenc
depict
sequenc
select
neg
sirna
control
sic
previou
studi
xu
et
al
sequenc
oligo
dna
synthes
shanghai
sangon
biolog
engin
technolog
servic
co
ltd
shanghai
china
sequenc
shown
tabl
oligonucleotid
anneal
ligat
bamh
hind
iii
site
ambion
austin
tx
usa
get
plasmid
sirna
sirna
repres
sic
get
promot
sirna
amplifi
pcr
use
plasmid
sirna
templat
follow
primer
shown
tabl
sirna
digest
ligat
xho
site
plnhx
clontech
mountain
view
ca
usa
form
plasmid
pln
sirna
insert
sequenc
confirm
sequenc
shanghai
sangon
biolog
engin
technolog
servic
co
packag
cell
line
clontech
mountain
view
ca
usa
grown
dmem
fc
gibco
mm
mm
mm
mem
sodium
uml
gml
streptomycin
cell
dish
transfect
fugen
hd
roch
indianapoli
usa
g
pvsvg
clontech
mountain
view
ca
usa
g
pln
sirna
fortyeight
hour
posttransfect
supernat
collect
filter
syring
filter
assay
well
cell
cultur
dish
seed
cell
next
day
cell
incub
cfu
coloni
form
unit
per
well
recombin
retroviru
contain
polybren
gml
final
concentr
h
c
follow
medium
replac
h
medium
remov
replac
fresh
medium
contain
gml
gibco
repeat
time
interv
day
coloni
monoclon
cell
screen
stabl
express
sirna
cell
clone
cul
tabl
primer
probe
use
studi
sequenc
ture
infect
tcid
csfv
strain
shimen
per
well
plate
incub
c
variou
time
period
indic
infect
cell
identifi
indirect
immunofluoresc
assay
infecti
viru
product
determin
tcid
assay
previous
describ
xu
et
al
copi
number
csfv
genom
rna
determin
realtim
rtpcr
integr
sirna
sirna
amplifi
nestedpcr
sirna
express
analysi
detect
rtpcr
realtim
rtpcr
quantit
viral
genom
primer
probe
use
utr
viral
genom
quantit
rtpcr
standard
primer
design
csfv
strain
shimen
use
vector
nti
amersham
piscataway
nj
usa
three
primer
synthes
purpos
shown
tabl
target
region
realtim
rtpcr
nt
utr
total
rna
csfvinfect
cell
extract
trizol
ls
reagent
invitrogen
carlsbad
ca
usa
appli
templat
synthesi
first
cdna
strand
utr
rtpcr
use
amv
revers
transcriptas
promega
madison
wi
usa
utr
primer
accord
manufactur
instruct
pcr
use
amplifi
utr
primer
condit
c
min
cycl
c
c
c
final
extens
c
min
pcr
product
gelpurifi
use
agaros
gel
dna
extract
kit
axygen
union
ca
usa
clone
pgemt
vector
promega
madison
wi
usa
result
plasmid
utr
correct
sequenc
confirm
direct
sequenc
select
quantit
standard
determin
viral
rna
copi
number
plasmid
prepar
store
c
determin
concentr
genequ
rnadna
calcul
quantit
analysi
csfv
genom
ng
total
rna
csfvinfect
cell
mix
l
primer
heat
c
min
chill
ice
min
primertempl
mix
ad
buffer
l
mmoll
dntp
l
rnasin
l
amv
revers
transcriptas
l
promega
madison
wi
usa
ddh
total
volum
l
reaction
mixtur
incub
c
min
follow
inactiv
revers
transcriptas
c
min
realtim
pcr
perform
abi
prism
sequenc
detect
system
use
l
transcriptas
product
templat
condit
c
min
follow
cycl
denatur
c
anneal
extens
c
quantit
standard
curv
determin
csfv
genom
copi
number
creat
realtim
pcr
standard
plasmid
utr
serial
dilut
stock
contain
copiesl
specif
realtim
pcr
confirm
sequenc
product
genom
extract
sirna
stabli
express
cell
passag
integr
sirna
sirna
amplifi
nestedpcr
plnfw
plnrev
outer
set
primer
inner
set
primer
shown
tabl
pcr
use
amplifi
sirna
gene
condit
c
min
cycl
c
c
c
final
extens
c
min
pcr
product
detect
agaros
gel
electrophoresi
specif
pcr
confirm
sequenc
inner
set
product
rna
sirna
stabli
express
cell
clone
prepar
use
mirvana
mirna
isol
kit
ambion
austin
tx
usa
accord
manufactur
protocol
one
hundr
ng
aliquot
sampl
rna
mix
revers
transcript
primer
x
repres
shown
tabl
primertempl
mix
ad
buffer
l
mmoll
dntp
l
rnasin
l
amv
revers
transcriptas
l
promega
madison
wi
usa
water
total
volum
l
rt
reaction
kept
c
min
c
min
termin
incub
mixtur
c
min
pcr
use
amplifi
primer
shortxrev
mpfw
mprev
condit
c
min
cycl
c
c
c
synthet
rnaoligonucleotid
use
posit
control
assay
posit
control
assay
perform
rt
ng
synthet
mixtur
ng
rna
cell
present
rna
cell
neg
control
rrna
chosen
housekeep
gene
primer
rrnafw
rrnarev
shown
tabl
method
describ
previous
sharbatitehrani
et
al
pcr
product
detect
polyacrylamid
gel
electrophoresi
numer
paramet
includ
genom
copi
viral
titer
express
mean
standard
deviat
student
test
use
analysi
numer
paramet
spss
window
spcc
inc
differ
consid
signific
p
valu
studi
inhibitori
effect
rna
interfer
csfv
replic
level
viral
antigen
produc
sirna
stabli
express
cell
examin
ifa
use
anticsfv
serum
viral
infect
h
postcsfv
infect
sic
stabli
express
cell
exhibit
bright
green
fluoresc
cytoplasm
indic
cell
control
produc
viru
fig
contrast
cell
stabli
express
display
green
fluoresc
indic
effect
protect
sirna
resist
viral
infect
increas
time
level
viral
antigen
increas
lower
level
control
quantit
effect
sirna
viral
replic
viral
genom
copi
number
determin
realtim
pcr
use
serial
dilut
plasmid
utr
standard
r
valu
standard
curv
averag
amplif
effici
e
calcul
formula
e
data
indic
realtim
pcr
highli
reliabl
assay
sequenc
show
fragment
amplifi
expect
part
utr
gene
therebi
demonstr
specif
reliabl
analysi
shown
fig
h
h
postvir
infect
copi
number
viral
genom
per
ng
total
rna
calcul
standard
curv
copiesng
viral
genom
total
rna
sic
stabli
express
cell
follow
gradual
decreas
titer
h
postinfect
h
postinfect
copi
number
ng
stabli
express
cell
respect
correspond
reduct
increas
time
copi
number
viral
genom
increas
h
postinfect
still
lower
sic
stabli
express
cell
tcid
assay
perform
examin
effect
sirna
product
viabl
viru
fig
show
titer
csfv
reach
tcid
ml
h
h
h
postinfect
respect
sic
stabli
express
cell
gradual
decreas
contrast
titer
h
postinfect
tcid
ml
sicstabl
express
cell
correspond
reduct
respect
titer
h
postinfect
tcid
ml
sicstabl
express
cell
respect
correspond
reduct
data
indic
sirna
markedli
inhibit
infecti
viru
product
increas
time
level
inhibit
decreas
amplif
templat
genom
dna
sirna
stabli
express
cell
nestedpcr
primer
result
amplifi
product
correspond
predict
size
outer
set
inner
set
bp
pcr
inner
set
product
sequenc
ident
confirm
sirna
product
amplifi
passag
ident
result
confirm
sirna
stabli
integr
target
cell
genom
rtpcr
use
test
express
sirna
two
sirna
posit
control
amplifi
product
predict
size
bp
fig
fail
produc
amplif
product
data
shown
express
rrna
gene
determin
housekeep
gene
product
size
bp
fig
result
indic
sirna
express
express
cell
fig
viabl
viral
product
three
sirna
stabli
express
cell
clone
mean
three
repeat
titrat
time
point
indic
p
vs
sic
stabli
express
cell
sirna
introduc
mammalian
cell
variou
mean
first
cell
transfect
chemic
synthes
sirna
vitrotranscrib
sirna
elbashir
et
al
xu
et
al
achiev
effect
rapid
silenc
target
gene
although
limit
cell
transfect
high
rate
effect
transient
circumv
latter
problem
socal
short
hairpin
rna
shrna
express
stabli
transfect
plasmid
kapadia
et
al
like
mirna
precursor
shrna
form
hairpin
structur
cleav
dicer
produc
sirna
howev
gener
shrnaexpress
cell
line
timeconsum
altern
way
achiev
stabl
integr
shrna
express
cassett
genom
cell
deliveri
via
retrovirus
schuck
et
al
product
fast
simpl
express
shrna
combin
express
select
marker
popul
everi
cell
contain
least
one
activ
copi
retrovir
genom
readili
obtain
studi
demonstr
use
retrovir
vectorbas
rnai
csfv
major
pathogen
pig
three
differ
sirna
gene
construct
deliv
via
replicationcompet
retrovir
vector
success
reduc
viral
replic
use
target
viral
gene
n
pro
two
key
gene
involv
csfv
replic
result
show
sirna
stabli
integr
express
cell
capabl
significantli
inhibit
viral
genom
rna
replic
csfv
genom
contain
singl
larg
orf
encod
polyprotein
meyer
et
al
sinc
n
pro
ultim
ntermin
proteas
involv
polyprotein
process
bind
sirna
n
pro
mrna
like
interf
translat
subsequ
process
viral
polyprotein
therebi
result
signific
inhibit
viral
replic
moreov
studi
show
essenti
sequenc
downstream
intern
ribosom
entri
site
within
start
region
csfv
mrna
singlestrand
high
effici
translat
ruggli
et
al
wilson
et
al
consequ
sinc
part
n
pro
mrna
may
form
secondari
structur
like
highli
access
sirna
kretschmerkazemi
far
sczakiel
indispens
cofactor
uncleav
format
infecti
particl
nterminu
serin
proteas
activ
moulin
et
al
uncleav
recruit
virion
assembl
requir
enzymat
activ
essenti
rna
replic
support
hypothesi
associ
independ
function
csfv
life
cycl
base
knowledg
satisfactori
rna
interfer
result
obtain
sirna
gener
key
gene
although
research
studi
effect
rnai
gene
done
studi
demonstr
use
retrovir
vectormedi
rnai
csfv
cell
standard
molecular
clone
techniqu
employ
construct
gener
differ
sirna
retrovirus
correspond
differ
region
csfv
genom
n
pro
retrovirus
infect
cell
express
sirna
combin
express
select
marker
sirna
stabli
express
cell
clone
obtain
everi
cell
clone
contain
least
one
activ
copi
sirna
knowledg
kinet
csfv
replic
cultur
cell
critic
determin
sampl
point
estim
sirna
effect
cell
henc
replic
kinet
csfv
strain
shimen
cell
studi
ifa
tcid
assay
prior
sirna
transfect
result
show
prolifer
viru
peak
h
postinfect
xu
et
al
base
consider
viral
growth
sirna
stabl
express
cell
determin
h
postinfect
silenc
csfv
gene
express
induc
sirna
stabli
express
cell
timedepend
shown
fig
signific
elev
viru
titer
seen
h
postinfect
sirna
stabli
express
cell
indic
effect
sirna
diminish
h
postinfect
cell
infect
sirna
stabli
express
cell
h
postinfect
h
exhibit
fluoresc
stabli
express
cell
sirnaexpress
cell
csfv
infect
passag
h
postinfect
almost
cell
infect
second
passag
data
shown
order
studi
sirna
effect
replic
kinet
csfv
studi
realtim
rtpcr
result
show
effect
inhibit
viru
replic
rtpcr
use
studi
show
specif
sirna
detect
easili
sirna
stabli
express
cell
suggest
effici
specif
sirna
express
sirna
stabli
express
cell
detect
express
yet
display
signific
inhibit
although
effici
consid
detect
level
one
could
argu
construct
may
actual
effect
two
sin
construct
sinc
rnai
highli
sequencespecif
requir
target
target
sequenc
ident
pestivirus
genet
variabl
overal
interspeci
sequenc
ident
within
genu
less
sequenc
ident
within
speci
vari
genet
varieti
make
imposs
design
sirna
abl
crossinhibit
speci
difficult
design
one
abl
inhibit
isol
within
speci
order
evalu
crossinhibitori
capabl
sirna
multipl
align
n
pro
sequenc
csfv
strain
conduct
base
avail
genbank
result
show
could
cover
csfv
strain
respect
data
shown
indic
addit
effort
undertaken
screen
sirna
widest
crossinhibitori
effect
rang
csfv
strain
therapi
anim
viral
infect
still
interest
concept
although
erad
worldwid
polici
especi
develop
countri
prevent
outbreak
infecti
diseas
studi
far
clearli
shown
prolong
inhibit
sirna
exampl
retrovir
mediat
suppress
hiv
transcript
singl
sirna
observ
year
suscept
hela
cell
line
yamagishi
et
al
studi
demonstr
retrovir
vectormedi
rnai
potenti
treatment
csfv
infect
method
may
inhibit
complet
viral
growth
merit
anim
studi
defin
real
therapeut
potenti
replicationcompet
retrovir
vector
sirna
genom
use
directli
treatment
addit
combin
use
differ
sirna
might
improv
effect
sirna
might
deliv
anim
via
transgen
mcgrew
et
al
part
vaccin
potenti
creat
virusresist
anim
popul
effect
sirna
combin
use
differ
replicationcompet
retrovir
vector
sirna
repeat
applic
concept
might
help
reduc
viral
transmiss
immun
gap
vaccin
onset
protect
therebi
gain
preciou
time
bring
outbreak
control
